Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Study completedNCT02323880What this trial is testingSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasWho this might be right forMalignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more Children's Oncology Group 59
Early research (Phase 1)Study completedNCT00994071What this trial is testingA Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsWho this might be right forMedulloblastomaPontine GliomaEpendymoma+2 more National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT04696029What this trial is testingDFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed MedulloblastomaWho this might be right forMedulloblastoma Giselle Sholler 118
Early research (Phase 1)Study completedNCT00063973What this trial is testingCilengitide in Treating Children With Refractory Primary Brain TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00268359What this trial is testingBevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory GliomasWho this might be right forBrain and Central Nervous System Tumors Duke University 68
Testing effectiveness (Phase 2)Study completedNCT00004688What this trial is testingPhase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsWho this might be right forAnaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more Emory University 35
Testing effectiveness (Phase 2)Study completedNCT03243851What this trial is testingStudy on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory GlioblastomaWho this might be right forGlioblastoma Yong-Kil Hong 81
Large-scale testing (Phase 3)Ended earlyNCT00761280What this trial is testingEfficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary GlioblastomaWho this might be right forAnaplastic AstrocytomaGlioblastoma Isarna Therapeutics GmbH 27
Early research (Phase 1)Active Not RecruitingNCT03500991What this trial is testingHER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsWho this might be right forCentral Nervous System Tumor, PediatricGliomaEpendymoma+6 more Seattle Children's Hospital 10
Early research (Phase 1)Study completedNCT00138216What this trial is testingTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 42
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Early research (Phase 1)WithdrawnNCT01182883What this trial is testingA Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid TumorsWho this might be right forBrain Stem NeoplasmsGliomaPinealoma National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00526812What this trial is testingA Safety Study of RTA 744 in Patients With Recurrent High-Grade GliomasWho this might be right forGlioma Biogen 54
Testing effectiveness (Phase 2)Looking for participantsNCT07424092What this trial is testingIntratumoral DNX-2401 for High Grade Pediatric Brain TumorsWho this might be right forHigh Grade GliomaEpendymomaEmbryonal Tumor of Brain+4 more Clinica Universidad de Navarra, Universidad de Navarra 39
Large-scale testing (Phase 3)Ended earlyNCT01987596What this trial is testingStudy of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With CancerWho this might be right forChildhood Choroid Plexus TumorChildhood MedulloblastomaChildhood Pineoblastoma+8 more Barbara Ann Karmanos Cancer Institute 23
Early research (Phase 1)Study completedNCT00003765What this trial is testingO6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT02684058What this trial is testingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsWho this might be right forDiffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+19 more Novartis Pharmaceuticals 151